SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Granddadx6
Search This Board:
Last Post: 9/29/2016 1:02:09 PM - Followers: 322 - Board type: Free - Posts Today: 4

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Statement of Changes in Beneficial Ownership (4) 09/20/2016 05:04:42 PM
ONVO News: Organovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in... 09/13/2016 08:05:00 AM
ONVO News: NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors 09/13/2016 06:00:00 AM
ONVO News: Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue 09/07/2016 08:05:00 AM
ONVO News: Securities Registration: Employee Benefit Plan (s-8) 08/26/2016 04:32:37 PM
#9373  Sticky Note ONVO 8K---EXCHANGE CHANGE; Granddadx6 07/26/16 08:13:34 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9600   Well look, this ain't SFOR I know, but RandolRocketman 09/29/16 01:02:09 PM
#9599   It's hard to believe? It's hard to believe RallyTheMarket 09/29/16 12:27:33 PM
#9598   Yep. It's kind of hard to believe this RandolRocketman 09/29/16 11:42:08 AM
#9597   Interesting spot here. nice upgrade. dshade 09/29/16 11:32:47 AM
#9596   Thomson Reuters/Verus upgrades ORGANOVO HOLDINGS INC from HOLD RandolRocketman 09/26/16 02:21:15 PM
#9595   Organovo announced their 3rd webinar for Sept 29th. BuckeyeStocks 09/22/16 06:36:21 PM
#9593   Keith Murphy is my hero... RandolRocketman 09/21/16 02:15:00 PM
#9592   Even better! BuckeyeStocks 09/20/16 11:00:33 PM
#9591   The Form 4 filed today represents a “sell WHP03 09/20/16 10:34:45 PM
#9590   Here's the link for the filing today: BuckeyeStocks 09/20/16 07:58:42 PM
#9589   Keith Murphy is disposing of a few shares BuckeyeStocks 09/20/16 07:58:17 PM
#9588   This board is really quiet for a good RandolRocketman 09/20/16 07:48:03 PM
#9587   Revenue growth is where it's at... if this WHP03 09/20/16 05:30:56 PM
#9586   Yeah and $5 seemed in sight three months. RallyTheMarket 09/20/16 04:55:44 PM
#9585   Looks like $3.85 is the resistance line to WHP03 09/20/16 03:05:26 PM
#9584   ONVO peers (per ONVO shareholder proxy) performance since WHP03 09/20/16 12:20:28 PM
#9583   GO BUCKS!! Young and hungry...looking very good PaperLion 09/20/16 02:17:29 AM
#9582   I will be there for sure. CIMA7 09/19/16 11:31:57 PM
#9581   TEDx SanDiego, October 22nd, 2016 scratchy 09/17/16 02:22:18 PM
#9580   Don't forget, Organovo has always intended to 3D RandolRocketman 09/16/16 12:47:45 PM
#9579   ONVO Benchmark (Exec Comp) Companies - 1 week WHP03 09/15/16 04:23:51 PM
#9578   Thanks for your technical analysis, it is insightful. BuckeyeStocks 09/14/16 04:35:50 PM
#9577   Thank you! Your input is appreciated and respected. Granddadx6 09/14/16 01:24:29 PM
#9576   The MotiveWave Elliott Wave Auto Tool is showing WHP03 09/14/16 11:48:00 AM
#9575   The technicals make me nervous as well. WHP03 09/14/16 11:02:52 AM
#9574   Any concern with the technical indicators lately? trailgirl 09/14/16 10:17:23 AM
#9573   Purchased more stock and more call options (Jan WHP03 09/13/16 04:15:58 PM
#9572   Here's an excerpt from the article: “This BuckeyeStocks 09/13/16 09:04:34 AM
#9571   Organovo press release: Organovo and Collaborators Publish BuckeyeStocks 09/13/16 08:51:31 AM
#9570   ONVO Benchmark Companies - last two trading days: WHP03 09/12/16 03:58:52 PM
#9569   Organovo to Test Pre-Clinical Drugs on Bio-Printed Kidney BuckeyeStocks 09/12/16 12:13:11 PM
#9568   It's all good. Being thrown out with the Granddadx6 09/09/16 03:36:31 PM
#9567   Always love Friday dshade 09/09/16 03:33:41 PM
#9566   Well, there goes that nice 6% pop on RandolRocketman 09/09/16 03:14:18 PM
#9565   long and stronger dshade 09/08/16 03:37:48 PM
#9564   ONVO in the News WHP03 09/08/16 01:21:41 PM
#9563   On various ONVO discussion boards - a few WHP03 09/08/16 12:07:12 PM
#9562   ONVO---GLTA! Granddadx6 09/08/16 09:27:50 AM
#9561   Well, the health of the chart is definitely WHP03 09/07/16 07:38:30 PM
#9560   Tutes, endowments, & pension funds loading all day crudeoil24 09/07/16 09:42:07 AM
#9559   >> " 3D bioprinting technology " << crudeoil24 09/07/16 09:36:35 AM
#9558   > ONVO IS A GREAT $$$$$ OPPORTUNITY. crudeoil24 09/07/16 09:32:46 AM
#9557   Company focused on growing revenues. Pay off time crudeoil24 09/07/16 09:13:24 AM
#9556   Last month several analysts initiated upgrades. crudeoil24 09/07/16 09:11:24 AM
#9555   imo, this stock (we) are sick and tired ddbl_our_buck 09/07/16 08:55:27 AM
#9554   ONVO 4.39 NEW$ [SMART MONEY] 09/07/16 08:55:24 AM
#9553   Organovo Announces Initiation of Commercial Contracting for ExVive Rkmatters 09/07/16 08:55:17 AM
#9552   Till the cows come home!! eomv ddbl_our_buck 09/07/16 08:39:44 AM
#9551   Congrats rando!! eom ddbl_our_buck 09/07/16 08:38:48 AM
#9550   19 minutes ago - DJNF crudeoil24 09/07/16 08:26:17 AM